Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Work In Process for 2 consecutive years, with $4.6 million as the latest value for Q4 2024.
- Quarterly Work In Process fell 1.31% to $4.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2024, down 1.31% year-over-year, with the annual reading at $4.5 million for FY2024, 4.69% down from the prior year.
- Work In Process for Q4 2024 was $4.6 million at Zhengye Biotechnology Holding, down from $4.7 million in the prior quarter.
- The five-year high for Work In Process was $4.7 million in Q4 2023, with the low at $4.6 million in Q4 2024.